Is there a link between Sezary syndrome and eosinophilia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Yes, there is a link between Sézary syndrome and raised eosinophils, as the malignant T cells in Sézary syndrome produce cytokines that stimulate eosinophil production and activation. Sézary syndrome, a rare and aggressive form of cutaneous T-cell lymphoma, is often associated with eosinophilia (elevated eosinophil counts in the blood) 1. This occurs because the malignant T cells in Sézary syndrome produce cytokines, particularly interleukin-4 (IL-4) and interleukin-5 (IL-5), which stimulate eosinophil production and activation. Some key points to consider:

  • Eosinophilia is reported in approximately 15-30% of Sézary syndrome patients and can be a useful diagnostic and prognostic marker.
  • The degree of eosinophilia may correlate with disease severity and progression in some cases.
  • When evaluating a patient with suspected Sézary syndrome, a complete blood count with differential should be performed to assess eosinophil levels, along with flow cytometry, skin biopsies, and other specialized tests.
  • Treatment of the underlying Sézary syndrome with appropriate therapies such as extracorporeal photopheresis, retinoids, interferon, histone deacetylase inhibitors, or chemotherapy typically leads to normalization of eosinophil counts as the disease responds to treatment 2. It's worth noting that while the exact mechanisms and relationships between Sézary syndrome and eosinophilia are complex and involve various cytokines and immune responses, the association between the two is supported by the production of specific cytokines by malignant T cells in Sézary syndrome 3, 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.